Intrinsic Value of S&P & Nasdaq Contact Us

Rocket Pharmaceuticals, Inc. RCKT NASDAQ

NASDAQ Global Market • Healthcare • Biotechnology • US • USD

SharesGrow Score
42/100
2/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$5.00
+28.9%

Rocket Pharmaceuticals, Inc. (RCKT) has 20 known insider and institutional holders on record. The largest holder is RTW INVESTMENTS, LP with 3,526,955 shares. Other notable holders include Shah Gaurav and Wilson Martin.

Over the last 12 months, insiders have made 63 transactions in RCKT stock — 25 buys (valued at $5.77M) and 32 sells (valued at $359.59K). Insider selling has exceeded buying during this period.

RCKT Insider Ownership

Top Holder
RTW INVESTMENTS, LP
3,526,955 shares
Buys (12 mo)
25
$5.77M value
Sells (12 mo)
32
$359.59K value
12-Month Transaction Activity
Buy 40%
Sell 51%
Top Insider Holders
# Name Role Shares Owned Last Filed Relative Size
1 Rtw Investments, Lp 10 Percent Owner, Other: See Remarks 3,526,955 2024-12-16
100%
2 Shah Gaurav CEO 1,046,055 2026-02-20
30%
3 Wilson Martin General Counsel 682,000 2026-02-20
19%
4 Patel Kinnari See Remarks 441,927 2025-05-22
13%
5 Makker Gotham Director 395,912 2025-07-18
11%
6 Schwartz Jonathan David See Remarks 299,064 2025-11-20
8%
7 Chaudhuri Sarbani See Remarks 189,076 2026-02-13
5%
8 Baumgartner Rudolph See Remarks 165,000 2016-03-24
5%
9 Mcvicar William K. See Remarks 135,000 2016-03-24
4%
10 Ondrey Aaron Chief Financial Officer 128,173 2025-07-08
4%
11 Baumgartner Rudolf A See Remarks 120,000 2017-01-24
3%
12 Stevens Christopher James Chief Operating Officer 93,037 2026-02-13
3%
13 Rizvi Syed Ali-aamir Chief Medical Officer 93,037 2026-02-13
3%
14 Militello John See Remarks 91,019 2026-02-20
3%
15 White Mark Andrew See Remarks 69,140 2024-11-04
2%
16 Bjork Elisabeth Director 50,000 2026-01-06
1%
17 Barberich Timothy J Director 45,000 2017-06-21
1%
18 Howes Paul G Director 45,000 2017-06-21
1%
19 Machado Patrick Director 45,000 2017-06-21
1%
20 Phillips Gary M. Director 45,000 2017-06-21
1%
Recent Transactions (last 12 months)
Date Name Role Type Shares Price Value
2026-02-18 Shah Gaurav CEO Informative Sell 5,990 $3.34 $19.99K
2026-02-18 Wilson Martin General Counsel Informative Sell 1,376 $3.34 $4.59K
2026-02-18 Militello John See Remarks Informative Sell 1,157 $3.34 $3.86K
2026-02-13 Shah Gaurav CEO Informative Sell 12,279 $3.31 $40.67K
2026-02-13 Wilson Martin General Counsel Informative Sell 12,253 $3.31 $40.58K
2026-02-13 Militello John See Remarks Informative Sell 3,726 $3.31 $12.34K
2026-02-11 Stevens Christopher James Chief Operating Officer RSU Award 93,037 $3.24 $301.44K
2026-02-11 Chaudhuri Sarbani See Remarks RSU Award 189,076 $3.24 $612.61K
2026-02-11 Rizvi Syed Ali-aamir Chief Medical Officer RSU Award 93,037 $3.24 $301.44K
2026-02-11 Shah Gaurav CEO RSU Award 870,648 $3.24 $2.82M
2026-02-11 Wilson Martin General Counsel RSU Award 468,187 $3.24 $1.52M
2026-02-11 Militello John See Remarks RSU Award 45,018 $3.24 $145.86K
2026-01-02 Bjork Elisabeth Director Informative Buy 10,000 $3.44 $34.4K
2025-11-18 Schwartz Jonathan David See Remarks Informative Sell 2,545 $2.98 $7.59K
2025-11-18 Shah Gaurav CEO Informative Sell 6,276 $2.98 $18.72K
2025-11-18 Wilson Martin General Counsel Informative Sell 1,646 $2.98 $4.91K
2025-11-18 Militello John See Remarks Informative Sell 1,086 $2.98 $3.24K
2025-11-03 Wilson Martin General Counsel RSU Award 100,000 - -
2025-10-14 Militello John See Remarks Informative Sell 558 $3.98 $2.22K
2025-10-06 Rizvi Syed Ali-aamir Chief Medical Officer RSU Award 283,018 - -
2025-09-24 Fong Peter Director RSU Award 23,333 - -
2025-09-24 Fong Peter Officer Unknown - - -
2025-09-19 Rtw Investments, Lp 10 Percent Owner, Other: See Remarks Option Exercise (ITM) 1 $17.81 $17.81
2025-09-15 Rizvi Syed Ali-aamir Officer Unknown - - -
2025-09-08 Schwartz Jonathan David See Remarks RSU Award 80,000 - -
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message